Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-048063

Chief Executive Officer bought 627,500 shares at $8.00 ($5,020,000)

  • Chief Executive Officer acquired 10,342,404 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wong Hing C Chief Executive Officer 2021-07-22 Conversion +6,316,691 10,602,405 D
Wong Hing C Chief Executive Officer 2021-07-22 Conversion +2,954,285 13,556,690 D
Wong Hing C Chief Executive Officer 2021-07-22 Conversion +1,071,428 14,628,118 D
Wong Hing C Chief Executive Officer 2021-07-22 Purchase +627,500 $8.00 $5,020,000 15,255,618 D
Derivatives
Wong Hing C Chief Executive Officer 2021-07-22 Conversion · Series A Redeemable Preferred Stock −6,316,691 0 D
Wong Hing C Chief Executive Officer 2021-07-22 Conversion · Series B Redeemable Preferred Stock −2,954,285 0 D
Wong Hing C Chief Executive Officer 2021-07-22 Conversion · Series C Redeemable Preferred Stock −1,071,428 0 D
Open-market purchases · 627,500 sh · avg $8.00 · $5,020,000
Loading xslF345X03/doc4.xml…